Meningitis Patient Factsheet and Vaccination Advice
Summary
The MHRA has published a patient factsheet on meningitis, providing information on the condition, its causes, symptoms, and the role of vaccination. The guidance also advises on reporting vaccine side effects through the Yellow Card scheme.
What changed
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a new patient factsheet detailing information about meningitis. The document covers the overview of meningitis, distinguishing between bacterial and viral forms, identifying at-risk age groups, and emphasizing the importance of vaccination. It also outlines common symptoms and provides instructions for reporting any adverse side effects related to meningitis vaccines via the Yellow Card scheme.
This guidance is primarily for public consumption and aims to inform patients and consumers about meningitis and its prevention. While it does not impose new regulatory obligations, it serves as an informational resource for healthcare providers and the public. Compliance officers should be aware of this guidance as it relates to public health information and the reporting of vaccine side effects, which may be relevant for pharmaceutical and healthcare entities.
What to do next
- Familiarize with the information provided in the meningitis patient factsheet.
- Ensure relevant patient-facing materials align with MHRA guidance on meningitis and vaccination.
- Reinforce procedures for reporting vaccine side effects through the Yellow Card scheme.
Source document (simplified)
Guidance
Meningitis – Patient Factsheet
Meningitis is a serious infection that can develop quickly and affect people of all ages
From: Medicines and Healthcare products Regulatory Agency Published 20 March 2026 Get emails about this page
Documents
Meningitis – Patient Factsheet
HTML
Details
Overview
Meningitis is an inflammation of the protective layers surrounding the brain and spinal cord. It is usually caused by a bacterial or viral infection and can develop quickly, sometimes requiring urgent medical treatment.
Although many people recover fully, infection with bacteria that cause meningitis can lead to serious complications, including life-threatening sepsis, if not treated promptly. Meningitis can affect people of all ages and can be caused by several different infections. Babies, young children, teenagers, young adults and older adults are at greater risk from infection. Viral meningitis will usually get better and rarely causes any long-term problems.
Vaccination is one of the safest and most effective ways to protect against the main causes of meningitis. Several routine NHS vaccines protect against the main bacterial infections that cause meningitis, helping to lower the risk of severe illness and long‑term complications.
This factsheet covers:
- Overview of meningitis
- Bacterial meningitis
- Viral meningitis
- Age and risk of meningitis
- Vaccines that protect against meningitis
- Safety and effectiveness of meningitis vaccines
- Meningitis symptoms
- Report side effects to the Yellow Card scheme
Published 20 March 2026 Get emails about this page Print this page
Named provisions
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Pharma & Drug Safety alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when MHRA Guidance & Safety publishes new changes.